- Home
- QH vs MDCX Comparison
QH vs MDCX Comparison
Compare QH & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QH | MDCX |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | China | United States |
| Employees | N/A | 16 |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8M | 16.6M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | QH | MDCX |
|---|---|---|
| Price | $3.42 | $0.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 155.8K | ★ 1.7M |
| Earning Date | 04-02-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.86 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.06 | $0.25 |
| 52 Week High | $10.85 | $3.69 |
Technical Indicators
Market Signals| Indicator | QH | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 58.61 | 47.14 |
| Support Level | $0.46 | $0.27 |
| Resistance Level | $7.76 | $0.36 |
| Average True Range (ATR) | 0.71 | 0.04 |
| MACD | 0.18 | 0.01 |
| Stochastic Oscillator | 31.84 | 40.45 |
Price Performance
Historical ComparisonAbout QH Quhuo Limited American Depository Shares
Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services. It generates maximum of its revenue from the on-demand delivery solutions segment.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.